ATLAS / Macro Radar / Reporting / RNXT

RenovoRx, Inc. (RNXT) reporting calendar

RenovoRx, Inc. files periodic reports with the SEC as RNXT on Nasdaq. Atlas tracks 19 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
21 Jul 2026 – 5 Sep 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
14 May 2026
Reports on record
19

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 44 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open RNXT market profile Latest filing on SEC EDGAR ↗ Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 202614 May 202644 days0001193125-26-224100
10-K31 Dec 202530 Mar 202689 days0001193125-26-131928
10-Q30 Sep 202513 Nov 202544 days0001493152-25-022304
10-Q30 Jun 202514 Aug 202545 days0001641172-25-024020
10-Q31 Mar 202515 May 202545 days0001641172-25-010935
10-K31 Dec 20241 Apr 202591 days0001641172-25-001932
10-Q30 Sep 202413 Nov 202444 days0001493152-24-045137
10-Q30 Jun 202413 Aug 202444 days0001493152-24-031675
10-Q31 Mar 202410 May 202440 days0001493152-24-018704
10-K31 Dec 20231 Apr 202492 days0001493152-24-012357
10-Q30 Sep 202313 Nov 202344 days0001493152-23-040598
10-Q30 Jun 202316 Aug 202347 days0001493152-23-029125
10-Q31 Mar 202312 May 202342 days0001493152-23-016648
10-K31 Dec 202231 Mar 202390 days0001493152-23-010332
10-Q30 Sep 202214 Nov 202245 days0001493152-22-031491
10-Q30 Jun 202212 Aug 202243 days0001493152-22-022384
10-Q31 Mar 202213 May 202243 days0001493152-22-013294
10-K31 Dec 202130 Mar 202289 days0001493152-22-008080
10-Q30 Sep 202115 Nov 202146 days0001493152-21-028585

Source: SEC EDGAR company submissions for CIK 0001574094. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.